The Clinical Signification of Claudin-11 Promoter Hypermethylation for Laryngeal Squamous Cell Carcinoma

BACKGROUND: Claudin-11 (CLDN11) is frequently silenced by its promoter hypermethylation. Previous studies have shown that CLDN11 promoter hypermethylation is a potential biomarker for diagnosing various cancers. The aim of this study was to investigate CLDN11 promoter methylation and its potential r...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Zhisen, Cao, Bing, Lin, Lexi, Zhou, Chongchang, Ye, Dong, Qiu, Shijie, Li, Qun, Cui, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Molecular Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541974/
https://www.ncbi.nlm.nih.gov/pubmed/28743857
http://dx.doi.org/10.12659/MSM.904751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541974/
https://www.ncbi.nlm.nih.gov/pubmed/28743857
http://dx.doi.org/10.12659/MSM.904751

Ejemplares similares